Sergey Parfenyev
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Epigenetics and DNA Methylation 7
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 3
- Cancer-related gene regulation 3
- Oncology 8
- Cancer-related Molecular Pathways 5
- Cancer Cells and Metastasis 2
- Co-authors
- Alexandra Daks (17 shared papers)Nickolai A. Barlev (12 shared papers)Olga Fedorova (10 shared papers)Oleg Shuvalov (16 shared papers)Aastha Singh (1 shared paper)Ritu Kulshreshtha (1 shared paper)Nickolai A. Barlev (8 shared papers)Hans‐Uwe Simon (2 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (7 papers)Antioxidants (2 papers)Biology Direct (2 papers)Cells (1 paper)Pharmaceuticals (1 paper)
- Partner nations
- RussiaKazakhstanSwitzerland
In The Last Decade
Sergey Parfenyev
21 papers receiving 259 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 61
- Reproductive Medicine 24
- Oncology 57
- Obstetrics and Gynecology 14
- Molecular Biology 139
Countries citing papers authored by Sergey Parfenyev
This map shows the geographic impact of Sergey Parfenyev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey Parfenyev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey Parfenyev more than expected).
Fields of papers citing papers by Sergey Parfenyev
This network shows the impact of papers produced by Sergey Parfenyev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey Parfenyev. The network helps show where Sergey Parfenyev may publish in the future.
Co-authors
The 25 scholars most cited alongside Sergey Parfenyev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 59 | |
| 2 | 2022 | 35 | |
| 3 | 2017 | 26 | |
| 4 | 2021 | 20 | |
| 5 | 2023 | 16 | |
| 6 | 2023 | 15 | |
| 7 | 2021 | 14 | |
| 8 | 2023 | 13 | |
| 9 | 2016 | 13 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 8 | |
| 12 | 2025 | 7 | |
| 13 | 2024 | 5 | |
| 14 | 2021 | 5 | |
| 15 | 2024 | 4 | |
| 16 | 2023 | 4 | |
| 17 | 2023 | 4 | |
| 18 | 2019 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2024 | 1 |
About Sergey Parfenyev
Sergey Parfenyev is a scholar working on Molecular Biology, Oncology, Cancer Research, Epidemiology and Biotechnology, having authored 22 papers that have together received 261 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (7 papers), Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (3 papers), Cancer-related gene regulation (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Cells and Metastasis (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Cancer Research (61 citations), Reproductive Medicine (24 citations), Oncology (57 citations), Obstetrics and Gynecology (14 citations) and Molecular Biology (139 citations). Sergey Parfenyev has collaborated with scholars based in Russia, Kazakhstan and Switzerland. Frequent co-authors include Alexandra Daks, Nickolai A. Barlev, Olga Fedorova, Oleg Shuvalov, Aastha Singh, Ritu Kulshreshtha, Nickolai A. Barlev, Hans‐Uwe Simon, Alexey Petukhov and Anna A. Pendina. Their work appears in journals such as Biochemical and Biophysical Research Communications, Antioxidants, Biology Direct, Cells and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.